Study of Early-stage Lung Adenocarcinoma for Early Detection and Effective Treatment Strategy

Samsung Medical Center

Status: Unknown

Conditions: Lung Adenocarcinoma

Treatments: Other: CT, PET, copy number alteration

Study type: Observational

Funder types: Other

Identifiers

NCT01482585

SMC 2011-09-083

Details and patient eligibility

About

to determine the values of imaging and genetic biomarkers for prediction of tumor aggressiveness and prognosis in patient with early stage lung adenocarcinoma to Identify unique copy number alteration in patient with early stage lung adenocarcinoma to evaluate the long-term change of ground-glass nodule combined with lung adenocarcinoma to suggest a guideline for planning an appropriate follow-up examination and management

Enrollment: 200 estimated patients

Sex: All

Ages: 20+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• A. Clinically and radiologically suspected lung adenocarcinoma
• B. Newly-diagnosed Stage I or II from the clinical work up including PET/CT
• C. Performance status of 0 to 1 on the ECOG scale
• D. Age 20 years or older
• E. Able to tolerable DECT imaging required by protocol
• F. Able to give study-specific informed consent

Exclusion criteria

• A. Prior malignancy
• B. planning of Definitive RTx 나 neoadjuvant CCRTx
• C. Poor cardiopulmonary reserve

Trial design

200 participants in 1 patient group

early stage lung adenocarcinoma

Treatment:

Other: CT, PET, copy number alteration